0001576280-24-000172.txt : 20240702 0001576280-24-000172.hdr.sgml : 20240702 20240702165826 ACCESSION NUMBER: 0001576280-24-000172 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240701 FILED AS OF DATE: 20240702 DATE AS OF CHANGE: 20240702 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Saia John G. CENTRAL INDEX KEY: 0001737840 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38683 FILM NUMBER: 241096640 MAIL ADDRESS: STREET 1: C/O ACELRX PHARMACEUTICALS, INC. STREET 2: 351 GALVESTON DRIVE CITY: REDWOOD CITY STATE: CA ZIP: 94063 FORMER NAME: FORMER CONFORMED NAME: Saia John DATE OF NAME CHANGE: 20180417 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Guardant Health, Inc. CENTRAL INDEX KEY: 0001576280 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 454139254 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3100 HANOVER STREET CITY: PALO ALTO STATE: CA ZIP: 94304 BUSINESS PHONE: 855-698-8887 MAIL ADDRESS: STREET 1: 3100 HANOVER STREET CITY: PALO ALTO STATE: CA ZIP: 94304 4 1 wk-form4_1719953898.xml FORM 4 X0508 4 2024-07-01 0 0001576280 Guardant Health, Inc. GH 0001737840 Saia John G. 3100 HANOVER STREET PALO ALTO CA 94304 0 1 0 0 Chief Legal Officer 0 Common Stock 2024-07-01 4 M 0 974 0 A 29391 D Common Stock 2024-07-01 4 F 0 348 28.26 D 29043 D Restricted Stock Units 0 2024-07-01 4 M 0 974 0 D Common Stock 974 8766 D These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability. This represents a restricted stock unit award granted on November 7, 2022 that vests over a four-year period. 25% of the shares subject to such award vests on October 1, 2023 and the remaining 75% of the shares vests in equal quarterly installments over the remaining three-year period thereafter. Not applicable for Restricted Stock Units. /s/ John G. Saia 2024-07-02